|Table of Contents|

Expression of GRK5 and Ki-67 in glioma tissues and analysis of its clinical significance

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2021 02
Page:
215-219
Research Field:
Publishing date:

Info

Title:
Expression of GRK5 and Ki-67 in glioma tissues and analysis of its clinical significance
Author(s):
ZHANG HuiFAN YuechaoCHEN HongfuJI PeizhiMIAO FaanCHEN Chen
Department of Cranial Base Tumor Surgery,Affiliated Hospital of Xuzhou Medical University,Jiangsu Xuzhou 221002,China.
Keywords:
gliomaGRK5Ki-67correlation
PACS:
R739.4
DOI:
10.3969/j.issn.1672-4992.2021.02.008
Abstract:
Objective:To investigate the expression of GRK5 and Ki-67 in glioma tissues,the relationship between the expression of GRK5 and Ki-67 in gliomas,and the prognostic value of GRK5 and Ki-67 in gliomas.Methods:This study collected tissue samples from 104 glioma patients who were surgically resected from January 2014 to January 2017 in our hospital and 20 normal brain tissues that were surgically resected by intracranial decompression due to intracranial injury during the same period.Immunohistochemical SP method was used to detect the expression levels of GRK5 and Ki-67 in glioma tissue and normal brain tissue.Spearman rank correlation analysis was used for correlation analysis.The chi-square test was used to analyze the correlation between the expression of GRK5 and Ki-67 in glioma tissues and the clinicopathological characteristics.Kaplan-Meier and Log-rank tests were used for survival analysis,and Cox proportional risk model was used for prognostic analysis.Results:The results of immunohistochemical detection showed that 66 cases of GRK5 were positively expressed in 104 glioma tissues,with a positive rate of 63.5%.2 cases were positively expressed in 20 normal brain tissues,with a positive rate of 10.0%.Ki-67 was positively expressed in 104 glioma tissues in 69 cases,with a positive rate of 66.3%.The positive expression rate was 0.0% in 20 normal brain tissues.Spearman rank correlation analysis showed that GRK5 and Ki-67 expressions were positively correlated in glioma tissues (r=0.558,P=0.000).The relationship between the expression of GRK5 and Ki-67 and the clinicopathological characteristics of glioma patients was analyzed.The results showed that the expression of GRK5 and Ki-67 was related to WHO grading (P<0.05),but not to gender,age,tumor diameter and tumor type (P>0.05).Survival analysis of 104 patients showed that the survival rate of GRK5 positive expression was significantly lower than the negative expression (P=0.033).The survival rate of Ki-67 positive expression was significantly lower than the negative expression (P=0.033).Cox regression model analysis showed that both GRK5 positive expression and Ki-67 positive expression were independent risk factors affecting the prognosis of glioma patients (P<0.05).Conclusion:GRK5 and Ki-67 are related to the occurrence,development and proliferation of gliomas.GRK5 and Ki-67 may be used as prognostic markers and indicators of clinical detection or combined detection in glioma patients to improve the clinical diagnosis rate.

References:

[1] YERSAL O,ODABASI E,OZDEMIR O,et al.Prognostic significance of pre-treatment neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with glioblastoma[J].Molecular and Clinical Oncology,2018,9(4):453-458.
[2] RAUSHAN A,NURZHAN R,AIDOS D,et al.Association of preoperative levels of selected blood inflammatory markers with prognosis in gliomas[J].OncoTargets and Therapy,2016(9):6111-6117.
[3] SOMMER AK,FALCENBERG M,LJEPOJA B,et al.Downregulation of GRK5 hampers the migration of breast cancer cells[J].Scientific Reports,2019,9(1):11548.
[4]李瑞瑞,蒋晓山.非视紫质G蛋白偶联受体激酶对肿瘤的调控作用[J].肿瘤防治研究,2019,46(04):367-370. LI RR,JIANG XS.The regulatory effect of non-visual purple protein G protein coupled receptor kinase on tumor [J].Cancer Prevention and Control Research,2019,46(04):367-370.
[5] LIEU M,KOCH WJ.GRK2 and GRK5 as therapeutic targets and their role in maladaptive and pathological cardiac hypertrophy[J].Expert Opinion on Therapeutic Targets,2019,23(3):201-214.
[6]马振坤,李磊.G蛋白偶联受体激酶-5调控前列腺肿瘤的生长[J].现代泌尿外科杂志,2012,17(02):207-208. MA ZK,LI L.G-protein-coupled receptor kinase-5 regulates the growth of prostate tumors [J].Journal of Modern Urology,2012,17(02):207-208.
[7]马宇彤,付鹏.PD-L1、Ki-67和BRAF V600E基因突变与甲状腺癌关系的研究进展[J].医学综述,2019,25(21):4233-4240. MA YT,FU P.Advances in studies on the relationship between mutations in PD-L1,Ki-67 and BRAF V600E genes and thyroid cancer [J].Medical Review,2019,25(21):4233-4240.
[8] LIU X,TIAN W,KOLAR B,et al.The correlation of fractional anisotropy parameters with Ki-67 index,and the clinical implication in grading of non-enhancing gliomas and neuronal-glial tumors[J].Magnetic Resonance Imaging,2020,65:129-135.
[9] BIELLE F.Building diagnoses with four layers:WHO 2016 classification of CNS tumors[J].Revue Neurologique,2016,172(4-5):253-255.
[10]贾蕾,史娟.抑制或过表达GRK5基因对星形胶质细胞凋亡及IL-1β和TNF-α表达的影响[J].中国免疫学杂志,2018,34(08):1163-1167. JIA L,SHI J.Effect of inhibition or overexpression of GRK5 gene on apoptosis of astrocytes and expression of IL-1 and TNF-α[J].Chinese Journal of Immunology,2018,34(08):1163-1167.
[11] GUREVICH VV,GUREVICH EV,TESMER JJG.G protein-coupled receptor kinases[J].Cell,2016,74(3):409-412.
[12] TRFIER A,GUILLOU F,CRPIEUX P.Investigation methods to explore G protein-coupled receptor-regulated translatome[J].C R Biol,2018,341(2):65-74.
[13] SCHUMACHER,SARAH M,KOCH,et al.Noncanonical roles of G protein-coupled receptor kinases in cardiovascular signaling[J].Journal of Cardiovascular Pharmacology,2017,70(3):129-141.
[14] 王菲菲,龙慧,陈跃军,等.G蛋白偶联受体激酶5在有丝分裂中的作用[J].中国细胞生物学学报,2012,34(03):234-239. WANG FF,LONG H,CHEN YJ,et al.The role of g-protein-coupled receptor kinase 5 in mitosis [J].Chinese Journal of Cell Biology,2012,34(03):234-239.
[15] CHAKRABORTY PK,ZHANG Y,COOMES AS,et al.G protein-coupled receptor kinase GRK5 phosphorylates moesin and regulates metastasis in prostate cancer[J].Cancer Research,2014,74(13):3489-3500.
[16] WU CC,TSAI FM,SHYU RY,et al.G protein-coupled receptor kinase 5 mediates Tazarotene-induced gene 1-induced growth suppression of human colon cancer cells[J].BMC Cancer,2011,11:175.
[17] KAUR G,KIN J,KAUR R,et al.G-protein coupled receptor kinase (GRK)-5 regulates proliferation of glioblastoma-derived stem cells[J].Journal of Clinical Neuroscience,2013,20(7):1014-1018.
[18] 周成美,程新宇.p62、p16和Ki-67在乳腺癌中的表达及临床意义[J].中国老年学杂志,2019,39(18):4560-4563. ZHOU CM,CHENG XY.Expression and clinical significance of p62,p16 and Ki-67 in breast cancer [J].Chinese Journal of Gerontology,2019,39(18):4560-4563.
[19] 崔凯,张利平.p16蛋白、Ki67抗原检测在宫颈上皮内瘤变中的诊断价值[J].检验医学与临床,2019,16(24):3704-3706. CUI K,ZHANG LP.The diagnostic value of p16 protein and Ki67 antigen in cervical intraepithelial neoplasia [J].Laboratory Medicine and Clinical Practice,2019,16(24):3704-3706.
[20]王娜,徐小艳,申洪,等.NEDD9、Ki67、P53联合检测对胃癌的早期诊断和恶性程度评估的价值[J].实用医学杂志,2017,33(12):1961-1965. WANG N,XU XY,SHEN H,et al.The value of NEDD9,Ki67 and P53 combined detection in the early diagnosis of gastric cancer and the evaluation of malignancy [J].Journal of Practical Medicine,2017,33(12):1961-1965.
[21] 齐兴峰,邱亚玲,陈丹丹,等.食管癌组织中Ki-67和VEGF的表达及其与放疗预后的关系[J].临床合理用药杂志,2019,12(34):44-46,48. QI XF,QIU YL,CHEN DD,et al.The expression of Ki-67 and VEGF in esophageal cancer tissues and its relationship with the prognosis of radiotherapy [J].Journal of Clinical Rational Use of Drugs,2019,12(34):44-46,48.

Memo

Memo:
江苏省卫生健康科研基金资助(编号:WJ2018G121)
Last Update: 1900-01-01